KISUNLA 350mg perfusive solution concentrate medication leaflet

N06DX05 donanemab • Nervous system | Anti-dementia drugs | Other anti-dementia drugs

General data about KISUNLA 350mg

Substance: donanemab

Date of last drug list: 01-11-2025

Commercial code: W71391001

Concentration: 350mg

Pharmaceutical form: perfusive solution concentrate

Quantity: 1

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: LILLY FRANCE - FRANTA

Holder: ELI LILLY NEDERLAND B.V. - TARILE DE JOS

Number: 1926/2025/01

Shelf life: 2 years

Other substances similar to donanemab